Not Yet RecruitingNCT03575000
Safety of bromocriptine added to antipsychotics for blood sugar changes
About this title
Read the official source — NCT03575000Medication studyAges 18+United StatesSchizophrenia
Understand this study
Who could participate?
This study is for people with schizophrenia. Listed age limits: from 18 years. Other eligibility criteria apply.
- Listed locations
- PittsburghSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateEstimated: January 1, 2026
- Recruitment status
- Not Yet Recruiting
- Enrollment listed in the registry
- 15
- Sponsor
- VA Pittsburgh Healthcare System
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT03575000
- Official title
Show the full official title
Open-label, Flexible-dose Adjunctive Bromocriptine for Patients With Schizophrenia and Prediabetes
Recruitment & locations
Not yet recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Pittsburgh
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is VA Pittsburgh Healthcare System.
Does this study involve medication?
Yes. The study involves medication, including Bromocriptine.
Who can participate?
This study is for people with schizophrenia. Listed age limits: from 18 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as not yet recruiting.
